Largest health care biotech companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Amgen leads the 24 health care biotech companies ranked by total assets, at AED 332.7B, ahead of Gilead Sciences (AED 216.8B) and Biogen (AED 108.1B). Figures as of 19 Nov 2026, 16:41 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- AmgenAED 332.7B
- Median
- AED 9.4B
- Combined market value
- AED 3.08T
- Countries
- 5
Market values as of .
All countries▾
Health Care▾
Biotech▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | AED 332.7B | AED 878B | AED 1,623.19 | 0.43% down | 32% up | ||
| 2 | Gilead SciencesGILD · Health Care | AED 216.8B | AED 764.4B | AED 616.28 | 0.70% down | 35% up | ||
| 3 | BiogenBIIB · Health Care | AED 108.1B | AED 135.6B | AED 917.11 | 0.68% down | 49% up | ||
| 4 | BioNTechBNTX · Health Care | AED 89.6B | AED 75.2B | AED 303.25 | 0.83% down | 14% down | ||
| 5 | ModernaMRNA · Health Care | AED 45.3B | AED 298.5B | AED 737.64 | 2.06% up | 780% up | ||
| 6 | argenxARGX · Health Care | AED 31.9B | AED 219B | AED 3,482.56 | 0.74% up | 2% up | ||
| 7 | QiagenQGEN · Health Care | AED 23.1B | AED 37.7B | AED 182.37 | 0.19% up | 9% up | ||
| 8 | Neurocrine BiosciencesNBIX · Health Care | AED 17B | AED 59.4B | AED 586.75 | 1.90% down | 17% up | ||
| 9 | VaxcytePCVX · Health Care | AED 11B | AED 35.1B | AED 222.01 | 3.30% up | 23% up | ||
| 10 | RepligenRGEN · Health Care | AED 10.8B | AED 41.4B | AED 647.44 | 2.09% up | 12% up | ||
| 11 | ExelixisEXEL · Health Care | AED 10.4B | AED 59.6B | AED 244.14 | 2.66% down | 63% up | ||
| 12 | Bio-TechneTECH · Health Care | AED 9.5B | AED 42B | AED 267.08 | 0.04% down | 24% up | ||
| 13 | Halozyme TherapeuticsHALO · Health Care | AED 9.3B | AED 39.2B | AED 343.91 | 2.25% down | 39% up | ||
| 14 | Revolution MedicinesRVMD · Health Care | AED 8.6B | AED 130.7B | AED 604.07 | 2.91% up | 129% up | ||
| 15 | CRISPR TherapeuticsCRSP · Health Care | AED 8.3B | AED 14.5B | AED 149.72 | 1.43% up | 18% down | ||
| 16 | Kymera TherapeuticsKYMR · Health Care | AED 6.4B | AED 37.7B | AED 441.99 | 0.65% down | 87% up | ||
| 17 | Krystal BiotechKRYS · Health Care | AED 4.9B | AED 34.5B | AED 1,164.10 | 0.51% up | 54% up | ||
| 18 | ImmunovantIMVT · Health Care | AED 3.5B | AED 25.3B | AED 122.12 | 0.24% up | 46% up | ||
| 19 | CG OncologyCGON · Health Care | AED 2.9B | AED 27.1B | AED 303.22 | 3.20% up | 97% up | ||
| 20 | Twist BioscienceTWST · Health Care | AED 2.4B | AED 30.8B | AED 452.27 | 5.84% up | 346% up | ||
| 21 | Adaptive BiotechnologiesADPT · Health Care | AED 1.9B | AED 17.7B | AED 109.41 | 4.67% up | 74% up | ||
| 22 | ImmunityBioIBRX · Health Care | AED 1.8B | AED 26.2B | AED 24.66 | 0.22% up | 232% up | ||
| 23 | Scholar Rock HoldingSRRK · Health Care | AED 1.5B | AED 22.5B | AED 184.04 | 4.40% up | 26% up | ||
| 24 | Kodiak SciencesKOD · Health Care | AED 1.3B | AED 23.7B | AED 362.86 | 1.01% up | 399% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6727 AED).
Questions and answers
Which health care biotech companies rank first by total assets?
Amgen (AED 332.7B), Gilead Sciences (AED 216.8B) and Biogen (AED 108.1B) are the top three of the 24 health care biotech companies ranked by total assets as of 19 Nov 2026, 16:41 UTC.
How many health care biotech companies are in this ranking?
24 are ranked by total assets.
What are these health care biotech companies worth together?
The 24 health care biotech companies ranked by total assets have a combined market value of AED 3.08T as of 19 Nov 2026, 16:41 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care biotech companies by total assets”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.